questionText: To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 31 October 2024 to Question 11248 on Coronavirus: Vaccination, what discussions the MHRA has had with industry safety regulators on the potential implications of the Pfizer study abstract entitled Post Conditional Approval Active Surveillance Study Among Individuals in Europe Receiving the Pfizer-BioNTech Coronavirus Disease 2019 (COVID-19) Vaccine dated 12 March 2024 on an assessment of individuals’ medical fitness to operate safety critical systems.
answerText: The study abstract has been reviewed by the Medicines and Healthcare products Regulatory Agency (MHRA), as part of its continuous post approval safety monitoring procedures for the Pfizer-BioNTech COVID-19 Vaccine (Comirnaty). The abstract is available at...
heading: Coronavirus: Vaccination